Bio-Techne number of employees

Bio-Techne reported 3,000 employees at June 30, 2026 in its latest annual report, down 100 (3.2%) on the year before. That compares with 3,000 at June 30, 2022. Revenue per employee was $405,013.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
June 30, 2026	3,000	−100 (3.2%)	$405,013	10-K, filed August 24, 2026
June 30, 2025	3,100	+0 (0.0%)	$393,431	10-K, filed August 22, 2025
June 30, 2024	3,100	+50 (1.6%)	$373,890	10-K, filed August 22, 2024
June 30, 2023	3,050	+50 (1.7%)	$372,689	10-K, filed August 23, 2023
June 30, 2022	3,000	—	$368,533	10-K, filed August 24, 2022

What the annual reports say

HUMAN CAPITAL Through its subsidiaries, Bio-Techne employed approximately 3,000 full-time and part-time employees as of June 30, 2026, of whom approximately 2,200 were employed in the U.S. and approximately 800 outside the U.S. 2026 annual report
HUMAN CAPITAL Through its subsidiaries, Bio-Techne employed approximately 3,100 full-time and part-time employees as of June 30, 2025, of whom approximately 2,300 were employed in the United States and approximately 800 outside the United States. 2025 annual report
HUMAN CAPITAL Through its subsidiaries, Bio-Techne employed approximately 3,100 full-time and part-time employees as of June 30, 2024, of whom approximately 2,300 were employed in the United States and approximately 800 outside the United States. 2024 annual report
HUMAN CAPITAL Through its subsidiaries, Bio-Techne employed approximately 3,050 full-time and part-time employees as of June 30, 2023, of whom approximately 2,400 were employed in the United States and approximately 650 outside the United States. 2023 annual report
HUMAN CAPITAL Through its subsidiaries, Bio-Techne employed approximately 3,000 full-time and part-time employees as of June 30, 2022, of whom approximately 2,300 were employed in the United States and approximately 650 outside the United States. 2022 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: SHC vs TECH RGEN vs TECH NEO vs TECH

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Bio-Techne's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bio-Techne.